Epidemiology of urinary tract infection in adults caused by extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae - a case-control study from Qatar

被引:7
|
作者
Naushad, Vamanjore A. [1 ,4 ,5 ]
Purayil, Nishan K. [1 ,4 ,5 ]
Wilson, Godwin J. [2 ,5 ]
Chandra, Prem [3 ]
Joseph, Prakash [1 ,4 ]
Khalil, Zahida [1 ,4 ]
Zahid, Muhammad [1 ,5 ]
Kayakkool, Muhammed K. [1 ,4 ,5 ]
Shaik, Noorjahan [1 ]
Ayari, Basma [1 ,5 ]
Chalihadan, Sajid [1 ]
Elmagboul, Emad Basheir I. [2 ]
Doiphode, Sanjay H. [2 ,5 ]
机构
[1] Hamad Gen Hosp, Gen Internal Med Dept, Hamad Med Corp, Doha, Qatar
[2] Hamad Med Corp, Dept Microbiol, Doha, Qatar
[3] Hamad Med Corp, Med Res Ctr, Doha, Qatar
[4] Qatar Univ, Coll Med, Doha, Qatar
[5] Weill Cornell Med, Ar Rayyan, Qatar
来源
IJID REGIONS | 2022年 / 3卷
关键词
ESBL; Urinary tract infections; Extended-spectrum beta-lactamase; Antibiotics; ESCHERICHIA-COLI; RISK-FACTORS; RESISTANCE TRENDS; COMMUNITY; SUSCEPTIBILITY; PREVALENCE; BACTERIA; CARE;
D O I
10.1016/j.ijregi.2022.05.001
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Community-acquired urinary tract infection (UTI) is the most common infection caused by extended -spectrum beta-lactamase (ESBL)-producing organisms. Aim: to estimate the prevalence of ESBL-UTI in adults and to identify potential risk factors that may predispose to ESBL-UTI. Methods: A retrospective study involving adult patients with UTI caused by ESBL-producing organisms was undertaken. Patients with UTI caused by non-ESBL-producing organisms represented the control group. Results: In total, 1100 UTI isolates were included in the study, 277 of which were ESBL positive. The prevalence rate was 25.2%. The mean age of patients was 55.87 years. On univariate analysis, prior history of UTI or ESBL-UTI, invasive urological procedure within preceding 3 months, hospital admission within preceding 3 months, and exposure to antibiotics were found to be significant risk factors for ESBL-UTI. On multi-variate analysis, use of cephalosporins [adjusted odds ratio (OR) 1.61, P = 0.048], previous ESBL-UTI (adjusted OR 2.67, P < 0.001), and invasive urological procedure in the preceding year (adjusted OR 1.61, P = 0.022) were found to be independent risk factors for ESBL-UTI. Conclusions: In Qatar, the prevalence of ESBL-UTI in adults is modest. Recent exposure to antibiotics, previous ESBL-UTI and invasive urological procedures were found to be independent risk factors for ESBL-UTI.
引用
收藏
页码:278 / 286
页数:9
相关论文
共 50 条
  • [41] Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum beta-Lactamase-Producing Enterobacteriaceae
    Lee, Bongjin
    Kang, Soo Young
    Kang, Hyun Mi
    Yang, Nu Ri
    Kang, Hee Gyung
    Ha, Il Soo
    Cheong, Hae Il
    Lee, Hoan Jong
    Choi, Eun Hwa
    INFECTION AND CHEMOTHERAPY, 2013, 45 (04): : 415 - 421
  • [42] Molecular Epidemiology of Extended-Spectrum Beta-Lactamase and AmpC Producing Enterobacteriaceae among Sepsis Patients in Ethiopia: A Prospective Multicenter Study
    Legese, Melese Hailu
    Asrat, Daniel
    Aseffa, Abraham
    Hasan, Badrul
    Mihret, Adane
    Swedberg, Gote
    ANTIBIOTICS-BASEL, 2022, 11 (02):
  • [43] Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae
    Kim, Se Ah
    Altshuler, Jerry
    Paris, Daryl
    Fedorenko, Marianna
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (01) : 155 - 158
  • [44] Extended-Spectrum β-Lactamase (ESBL)-Producing Enterobacteriaceae: A Threat from the Kitchen
    Tschudin-Sutter, Sarah
    Frei, Reno
    Stephan, Roger
    Haechler, Herbert
    Nogarth, Danica
    Widmer, Andreas F.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2014, 35 (05): : 581 - 584
  • [45] Colonisation with extended-spectrum beta-lactamase (ESBL) not detected in a prevalence study
    O'Connor, C.
    Kiernan, M. G.
    Finnegan, C.
    Powell, J.
    Power, L.
    O'Connell, N. H.
    Dunne, C. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (03) : 723 - 727
  • [46] Extended-spectrum β-lactamase-producing Enterobacteriaceae, national study of antimicrobial treatment for pediatric urinary tract infection
    Lagree, M.
    Bontemps, S.
    Dessein, R.
    Angoulvant, F.
    Madhi, F.
    Martinot, A.
    Cohen, R.
    Dubos, F.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (03): : 193 - 201
  • [47] Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae
    Lowe, Christopher F.
    Katz, Kevin
    McGeer, Allison J.
    Muller, Matthew P.
    PLOS ONE, 2013, 8 (04):
  • [48] Epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a UK district hospital; an observational study
    Enoch, D. A.
    Brown, F.
    Sismey, A. W.
    Mlangeni, D. A.
    Curran, M. D.
    Karas, J. A.
    Cone, D. B.
    Aliyu, S. H.
    Dhanji, H.
    Doumith, M.
    Maharjan, S.
    Meunier, D.
    Woodford, N.
    JOURNAL OF HOSPITAL INFECTION, 2012, 81 (04) : 270 - 277
  • [49] Urinary Tract Infection Caused by Extended-Spectrum Beta-Lactamase-Producing Bacteria in Kidney Transplant Patients
    Pinheiro, H. S.
    Mituiassu, A. M.
    Carminatti, M.
    Braga, A. M.
    Bastos, M. G.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 486 - 487
  • [50] Prevalence and Risk Factors of Fecal Carriage of Extended-Spectrum beta-lactamase (ESBL) - Producing Enterobacteriaceae in Hospitalized and Ambulatory Children
    Kiremitci, Abdurrahman
    Dinleyici, Ener Cagri
    Yargic, Zeynel Abidin
    Durmaz, Gul
    Tekin, Neslihan
    Aybey, Askin Derya
    Aksit, Mehmet Arif
    JOURNAL OF PEDIATRIC INFECTION, 2011, 5 (02): : 54 - 58